Statins in hemorrhagic stroke

Expert Review of Neurotherapeutics

Volumn 11, Issue 8, 2011, Pages 1141-1149

  Flaster, Murray ^a   Morales Vidal, Sarkis ^a   Schneck, Michael J ^a   Biller, José ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

hypertension; ICH; LDL C; SAH; statin pleiotropic effects; statin withdrawal

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ROSUVASTATIN; SIMVASTATIN;

BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG MECHANISM; DRUG WITHDRAWAL; HUMAN; HYPERTENSION; REVIEW; STROKE; SUBARACHNOID HEMORRHAGE;

CORONARY ARTERY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTRACRANIAL HEMORRHAGES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE; TREATMENT OUTCOME;

EID: 79961076086     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.11.101     Document Type: Review

References (79)

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).Lancet 344 (8934), 1383-1389 (1994).
2. LaRosa JC, He Jiang, Vupputuri S. Effect of statins on risk of coronary disease. A meta-analysis of randomized controlled trials. JAMA 282 (24), 2340-2346 (1999). (Pubitemid 30013066)
3. Amarenco P, Bogousslavsky J, Callahan A et al. High-dose atorvastatin after stroke or transient ischemic attack. N. Engl. J. Med. 355(6), 549-559 (2006). (Pubitemid 44202151)
4. Amarenco, P, Labreuche J, Lavallée P, Touboul PJ. Statins in stroke prevention and carotid atherosclerosis. Systematic review and up-to-date meta-analysis. Stroke 35, 2902-2909 (2004). (Pubitemid 39565192)
5. Ridker PM, Danielson E, Fonseca FAH et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med. 359(21), 2195-2207 (2008).
6. Everett BM, Glynn RJ, MacFadyen JG, Ridker PM. Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein. Circulation 121, 143-150 (2010).
7. DeCaterina R, Scarano M, Marfisi RM et al. Cholesterol-lowering interventions and stroke. J. Am. Coll. Cardiol. 55(3), 198-211 (2010).
8. Sadowitz B, Maier K, Gahtan V. Statin therapy - part 1: the pleiotropic effects of statins in cardiovascular disease. Vasc. Endovascular Surg. 44(4), 241-251 (2010).
9. Zipp F, Waiczies S, Aktas O et al. Impact of HMG-CoA reductase inhibition on brain pathology. Trends Pharmacol. Sci. 28(7), 342-349 (2007). (Pubitemid 47016681)
10. Willey JZ, Mitchell S, Elkind V. 3-Hydroxy-3-methylglutary 1-coenzyme A reductase inhibitors in the treatment of central nervous system diseases. Arch. Neurol. 67, 1062-1067 (2010).
11. Biffi A, Devan WJ, Anderson CD et al. Statin treatment and functional outcome after ischemic stroke. Stroke 42, 1314-1319 (2011).
12. McGuinness B, O'Hare J, Craig D. Statins for the treatment of dementia. Cochrane Datase Syst. Rev. 8, CD007514 (2010).
13. Buhaescu I, Izzedine H. Mevalonate pathway: a review of clinical and therapeutical implications. Clin. Biochem. 40, 575-584 (2007). (Pubitemid 46829082)
14. Endres M, Laufs U. Effects of statins on endothelium and signaling mechanisms. Stroke 35, 2708-2711 (2004). (Pubitemid 39458376)
15. Kwak B, Mulhaupt F, Myit S, Mach F. Statins as a newly recognized type of immunomodulator. Nat. Med. 6 (12), 1399-1402 (2000). (Pubitemid 32001026)
16. Chen J, Zhany ZG, Li Y et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann. Neurol. 53, 743-751 (2003). (Pubitemid 36622511)
17. Jung KH, Chu K, Jeong SW et al. HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recover, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage. Stroke 35, 1744-1749 (2004). (Pubitemid 38823658)
18. Chopp M, Zhang ZG, Jiang Q. Neurogenesis, angiogenesis, and MRI indices of functional recovery from stroke. Stroke 38, 827-831 (2007). (Pubitemid 46184266)
19. Karki K, Knight RA, Han Y et al. Simvastatin and atorvastatin improve neurological outcome after experimental intracerebral hemorrhage. Stroke 40, 3384-3389 (2009).
20. Shepherd J, Blauw GJ, Murphy MB et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet 360, 1623-1630 (2002). (Pubitemid 35379733)
21. McGirt MJ, Lynch JR, Parra A et al. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 33, 2950-2956 (2002). (Pubitemid 35462871)
22. Fleming I, Busse R. Endothelial dysfunction: a novel therapeutic target. NO: the primary EDRF. J. Mol. Cell. Cardiol. 31, 5-14 (1999).
23. McGirt MJ, Blessing R, Alexander MJ et al. Risk of cerebral vasospasm after subarachnoid hemorrhage reduced by statin therapy: a multivariate analysis of an institutional experience. J. Neurosurg. 105, 671-674 (2006). (Pubitemid 44703927)
24. Lynch JR, Wang H, McGirt MJ et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage. Results of a pilot randomized clinical trial. Stroke 36, 2024-2026 (2005). (Pubitemid 41266547)
25. Chou SHY, Smith EE, Badjatia N et al. A randomized, double-blind placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage. Stroke 39, 2891-2893 (2008).
26. Tseng MY, Hutchinson PJ, Czosnyka M. Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage. Stroke 38, 1545-1550 (2007). (Pubitemid 46684172)
27. Rinkel GJE, Klijn CJM. Prevention and treatment of medical and neurological complications in patients with aneurysmal subarachnoid haemorrhage. Pract. Neurol. 9, 195-209 (2009).
28. Sillberg VAH, Wells GA, Perry JJ. Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage. A meta-analysis. Stroke 39, 2622-2626 (2008).
29. Kramer AH. Statins in the management of aneurysmal subarachnoid hemorrhage - not (yet) a standard of care. Letters to the editor. Stroke 40, e80-e81 (2009).
30. Cook AM, Hessel EA. Meta-analysis of statins for aneurysmal subarachnoid hemorrhage falls short. Stroke 40, e79 (2009).
31. Vergouwen MDI, Meijers JCM, Geskus RB et al. Biologic effects of simvastatin in patients with aneurismal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial. J. Cereb. Blood Flow Metab. 29, 1444-1453 (2009).
32. Vergouwen MDI, de Haan RJ, Vermeulen M et al. Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage. A systematic review and meta-analysis update. Stroke 41, e47-e52 (2010).
33. Kramer AH, Fletcher JJ. Statins in the management of patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurocrit. Care 12, 285-296 (2010).
34. McGirt MJ, Ambrossi GLG, Huang J, Tamargo RJ. Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a single-institution prospective cohort study. J. Neurosurg. 110, 268-274 (2009).
35. Singhal AB, Topcuoglu MA, Dorer DJ et al. SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage. Neurology 64, 1008-1013 (2005). (Pubitemid 40388453)
36. Risselada R, Straatman H, van Kooten F et al. Withdrawal of statins and risk of subarachnoid hemorrhage. Stroke 40, 2887-2892 (2009).
37. Moskowitz SI, Ahrens C, Provencio JJ et al. Prehemorrhage statin use and the risk of vasospasm after aneurysmal subarachnoid hemorrhage. Surg. Neurol. 71, 311-318 (2009).
38. Laufs U, Endres M, Custodis F et al. Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of Rho GTPase gene transcription. Circulation 102, 3104-3110 (2000).
39. Puccetti L, Pasqui AL, Pastorelli M et al. Platelet hyperactivity after statin treatment discontinuation. Thromb. Haemost. 90, 476-482 (2003). (Pubitemid 37138773)
40. Morgenstern LB, Hemphill JC, Anderson C et al. Guidelines for the management of spontaneous intracerebral hemorrhage. A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 41, 2108-2129 (2010).
41. Shimamoto T, Komachi Y, Inada H et al. Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation 79, 503-515 (1989). (Pubitemid 19087701)
42. Iso H, Jacobs DR, Wentworth D. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N. Engl. J. Med. 320(14), 904-910 (1989). (Pubitemid 19101595)
43. Yano K, Reed DM, MacLean CJ. Serum cholesterol and hemorrhagic stroke in the Honolulu heart program. Stroke 20, 1460-1465 (1989). (Pubitemid 19278129)
44. Leppala JM, Virtamo J, Fogelholm R et al. Different risk factors for different stroke subtypes. Association of blood pressure, sholesterol, and antioxidants. Stroke 30, 2535-2540 (1999).
45. Woo D, Kissela BM, Khoury JC et al. Hypercholesterolemia, HMG-CoA reductase inhibitors, and risk of intracerebral hemorrhage. A case-control study. Stroke 35, 1360-1364 (2004).
46. Noda H, Iso H, Irie F et al. Low-density lipoprotein cholesterol concentrations and death due to intraparenchymal hemorrhage. Circulation 119, 2136-2145 (2009).
47. Ebrahim S, Sung J, Song YM et al. Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study. BMJ 333(7557), 22 (2006).
48. Goldstein LB, Amarenco P, Szarek M et al. Hemorrhagic stroke in the stroke prevention by aggressive reduction in cholesterol levels study. Neurology 70, 2364-2370 (2008).
49. Collins R, Armitage J, Parish S et al. Effects of the cholesterol-lowering with simvastatin on stroke and other majorvascular events in 20,536 people with cerebrovascular disease or other high-risk conditions. Lancet 363, 757-767 (2004).
50. Vergouwen MDI, de Haan RJ, Vermeulen M et al. Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke 39, 497-502 (2008). (Pubitemid 351619482)
51. Westover MB, Bianchi MT, Eckman MH et al. Statin use following intracerebral hemorrhage. Arch. Neurol. 68, 573-579 (2011).
52. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366, 1267-1278 (2005).
53. O'Regan C, Wu P, Arora P et al. Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients. Am. J. Med. 121, 24-33 (2008).
54. Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol. 8, 453-463 (2009).
55. Karki K, Knight RA, Han Y et al. Simvastatin and atorvastatin improve neurological outcome after experimental intracerebral hemorrhage. Stroke 40, 3384-3389 (2009).
56. Biffi A, Devan WJ, Anderson CD et al. Statin use and outcome after intracerebral hemorrhage. Case control study and meta-analysis. Neurology 76, 1581-1588 (2011).
57. Fitz Maurice E, Wendell L, Snider R et al. Effect of statins on intracerebral hemorrhage outcome and recurrence. Stroke 39, 2151-2154 (2008).
58. Ricard G, Garant MP, Carrier N et al. Statins may increase intracerebral hemorrhage volume. Can. J. Neurol. Sci. 37, 791-796 (2010).
59. Eichel R, Khoury ST, Ben-Hur T et al. Prior use of statins and outcome in patients with intracerebral haemorrhage. Eur. J. Neurology 17, 78-83 (2010).
60. Meier N, Nedeltchev K, Brekenfeld C et al. Prior statin use, intracranial hemorrhage, and outcome after intra-arterial thrombolysis for acute ischemics. Stroke 40, 1729-1737 (2009).
61. Bang OY, Saver JL, Liebeskind DS et al. Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis. Neurology 68, 737-742 (2007). (Pubitemid 46667898)
62. Uyttenboogaart M, Koch MW, Koopman K et al. Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke. J. Neurol. 255, 875-880 (2008).
63. Tapia-Perez H, Sanchez-Aguilar M, Torres-Corzo JG et al. Use of statins for the treatment of spontaneous intracerebral hemorrhage: results of a pilot study. Cen. Eur. Neurosurg. 70(1), 15-20 (2009).
64. Naval NS, Abdelhak TA, Urrunaga N et al. An association of prior statin use with decreased perihematomal edema. Neurocrit. Care 8, 13-18 (2008). (Pubitemid 351378100)
65. Westphal S, Albletshauser C, Luley C. Fluvastatin treatment and withdrawal: effects on endothelial function. Angiology 59(5), 613-618 (2008).
66. Rosengarten B, Auch D, Kaps M. Effects of initiation and acute withdrawal of statins on the neurovascular coupling mechanism in healthy, normocholesterolemic humans. Stroke 38, 3193-3197 (2007). (Pubitemid 350175736)
67. Thomas M, Mann J. Increased thrombotic vascular events after change of statin. Lancet 352, 1830-1831 (1998). (Pubitemid 28550081)
68. Heeschen C, Hamm CW, Laufs U et al. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation 105, 1446-1452 (2002). (Pubitemid 34263276)
69. Blanco M, Nombela F, Castellanos M et al. Statin treatment withdrawal in ischemic stroke. A controlled randomized study. Neurology 69, 904-910 (2007). (Pubitemid 47329591)
70. Colivicchi F, Bassi A, Santini M, Caltagirone C. Discontinuation of statin therapy and clinical outcome after ischemic stroke. Stroke 38, 2652-2657 (2007). (Pubitemid 47493999)
71. LeManach Y, Godet G, Coriat P et al. The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesth. Analg. 104, 1326-1333 (2007). (Pubitemid 46795280)
72. Kruger P, Fitzsimmons K, Cook D et al. Statin therapy is associated with fewer deaths in patients with bacteraemia. Intensive Care Med. 32(1), 11-14 (2006).
73. Kruger PS, Harward ML, Jones MA et al. Continuation of statin therapy in patients with presumed infection. A randomized controlled trial. Am. J. Respir. Crit. Care Med. 183, 774-781 (2011).
74. Smith EE, Nandigam KRN, Chen YW et al. MRI markers of small vessel disease in lobar and deep hemispheric intracerebral hemorrhage. Stroke 41, 1933-1938 (2010).
75. Reed DM. The paradox of high risk of stroke in population with low risk of coronary heart disease. Am. J. Epidemiol. 131(4), 679-688 (1990).
76. Zia E, Hedblad B, Pessah-Rasmussen H et al. Blood pressure in relation to the incidence of cerebral infarction and intracerebral hemorrhage. Hypertensive hemorrhage: debated nomenclature is still relevant. Stroke 38, 2681-2685 (2007). (Pubitemid 47494004)
77. Bronner LL, Kanter DS, Manson JE. Primary prevention of stroke. N. Engl. J. Med. 333(21), 1392-1400 (1995).
78. Ariesen MJ, Claus SP, Rinkel GJE et al. Risk factors for intracerebral hemorrhage in the general population. A systematic review. Stroke 34, 2060-2066 (2003).
79. Smith EE. Leukoaraiosis and stroke. Stroke 41(Suppl. 1), S139-S143 (2010).